CDC PLACES February 2023 Newsletter

February 22, 2023

PLACES provides model-based, population-level analysis and community estimates of health measures to all counties, incorporated and census-designated places, census tracts, and ZIP Code Tabulation Areas (ZCTAs) across the United States. Learn more about PLACES.

2023 Release of Chronic Disease Indicators

	Chronic disease indicators (CDIs) provide state-level estimates of chronic disease measures that complement local PLACES estimates. Explore health measures across 18 topic areas with over 200 measures.

February Health Observances

American Heart Month Find related estimates in the PLACES Interactive Map and Data Portal: • Coronary heart disease. • Stroke. • High blood pressure. • High cholesterol. • Blood pressure medication. • Cholesterol screening. Learn more about CDC and its partners’ initiatives on heart disease prevention at Live to the Beat and Million Hearts®. Visit CDC’s Division of Heart Disease and Stroke Prevention for more resources.

Cancer Prevention Month Find related estimates in the PLACES Interactive Map and Data Portal: • Cancer. • Cervical cancer screening. • Mammography use. • Colorectal cancer screening. Learn more about CDC’s programs, services, and partnerships focusing on cancer prevention and early detection at Inside Knowledge campaign and Screen for Life: National Colorectal Cancer Action campaign. Visit CDC’s Division of Cancer Prevention and Control for more resources.

PLACES in Practice  CDC’s Division of Nutrition, Physical Activity, and Obesity is using PLACES obesity estimates to determine eligibility for the High Obesity Program 2023. The High Obesity Program funds land grant universities to work with community extension services to increase access to healthier foods and safe and accessible places for physical activity in counties that have more than 40% of adults with obesity. How is your team using PLACES data? Please share your stories and experience with us by emailing PLACES@cdc.gov. You can also send questions to this mailbox. Click here to email the PLACES team!

More Information

PLACES Data Portal	FAQs	PLACES Interactive Map	Help section

Centers for Disease Control and Prevention 1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348 Questions or Problems  |  Unsubscribe

New CDC data on dialysis & resistant infections

Report: Patients on dialysis more likely to have staph infections

CDC Vital Signs Report: Patients on Dialysis at Higher Risk for Bloodstream Infections S. aureus can cause difficult-to-treat, resistant infections

According to a recent CDC Vital Signs report, more than 14,000 bloodstream infections occurred in patients on dialysis in the United States in 2020, and more than one in three were caused by Staphylococcus aureus (S. aureus, or staph). Of those infections, 40% were caused by methicillin-resistant S. aureus (MRSA). MRSA is resistant to several antibiotics, making it difficult to treat, and is a serious threat in the United States, according to CDC’s 2019 Antibiotic Resistance Threats Report.  The Vital Signs report highlights that staph bloodstream infections happen more often in Black and Hispanic patients on dialysis than White patients on dialysis. Areas in the United States with higher poverty, household crowding, and lower education also accounted for more dialysis staph bloodstream infections.

Bloodstream infections are preventable in all patients on dialysis, and actions to reduce inequities can save lives. Preventing these infections requires a broad and equitable approach. Healthcare providers and patients can:	Adults on dialysis treatment for end-stage kidney disease were 100 times more likely to have a staph bloodstream infection than adults not on dialysis during 2017-2020

Manage conditions such as diabetes and high blood pressure to prevent chronic kidney disease. Stay informed about end-stage kidney disease treatments. Reduce use of central venous catheters for dialysis treatment. Fistulas have the lowest risk of infection and central venous catheters have the highest risk of infection. Reduce barriers for patients to receive medical care such as transportation assistance and resources in appropriate languages. Know sepsis signs and symptoms to identify and treat patients early.

Centers for Disease Control and Prevention 1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348 Questions or Problems  |  Unsubscribe

New Map Shows CDC Investments to Fight AR

Explore antimicrobial resistance (AR) investments in your state

Updated Map Shows CDC’s Investments to Fight Antimicrobial Resistance Explore activities happening in your state or country

Today, CDC released the updated Antimicrobial Resistance (AR) Investment Map, highlighting CDC’s AR funding to global and domestic partners—from academic centers to local public health departments. These partners work alongside CDC to implement innovative solutions to slow the spread of AR, improve infection prevention and control (IPC), and protect people. CDC’s investments have strengthened U.S. and global capacities to rapidly detect, respond to, and contain existing and emerging AR threats.

Each year, more than 3 million people get an antimicrobial-resistant infection or Clostridioides difficile infection (often associated with taking antibiotics). In fiscal year 2022, CDC invested more than $120 million of annual funding to support health departments and partners in the United States and abroad to combat and prevent antimicrobial-resistant infections. CDC also invested more than $900 million from temporary supplemental funding to fight a range of infections that threaten the nation’s health, including those caused by AR organisms, COVID-19, and other known and emerging infectious diseases. However, when supplemental funds end, CDC will not be able to continue supporting work at the level shown in the current AR Investment Map. This will risk progress in combating AR and strengthening IPC and outbreak response across One Health.

Highlights of this year’s AR Investment Map release include: An interactive map showcasing CDC’s AR funding to support activities in every U.S. state health department and across hundreds of public health partners An updated fact sheet featuring CDC’s global investments with partners in more than 50 countries to improve detection, prevention, and response to AR threats internationally An updated fact sheet showing how CDC’s COVID-19 supplemental funding has supported efforts that also address AR, including investments in IPC; training and capacity building, such as Project Firstline; surveillance; and public health personnel CDC leads the U.S. public health response to combat AR, a threat that continues to emerge and spread across the world. CDC’s AR Solutions Initiative invests in national infrastructure to detect, respond to, contain, and prevent resistant infections across healthcare settings, communities, the food supply, and the environment (water, soil).

	Germs can spread quickly across countries and continents. #CDCfightsAR with millions in investments to support lab, epi, and innovation in the U.S. & more than 50 countries this year: https://bit.ly/ARInvestMap

Centers for Disease Control and Prevention 1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348 Questions or Problems  |  Unsubscribe

ACIP: Vaccine Recommendation Updates - 2/16/2023

If you received this as a forwarded email, Subscribe now to receive future updates to CDC ACIP recommendations.

You are receiving this email because you opted in to receive updates for the page below.   Revisions have been made to the ACIP General Best Practice Guidelines for Immunization.    To see the revisions, please go to ACIP List of Errata/Updates for Guidelines for Immunization.

View Now

Centers for Disease Control and Prevention 1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348 Questions or Problems  |  Unsubscribe

2023 Recommended Immunization Schedules Now Online

2023 Recommended Immunization Schedules Now Online

The 2023 ACIP Recommended Immunization Schedules were released today. In collaboration with our healthcare partners, CDC has updated versions of the recommended U.S. immunization schedules for children and teens as well as for adults.   Several additional formats of the schedules, including parent-friendly versions, are available on the CDC Immunization Schedules website.	Schedule Changes & Guidance     Download Schedules App for Health Care Providers     Syndicate the Schedules on your Website     Routine Immunizations on Schedule for Everyone (RISE)

	Child and Adolescent Immunization Schedule

Recommended Immunization Schedules for Persons Aged 0 Through 18 Years, U.S., 2023   This schedule includes the age-based routine vaccination schedule for children and teens and the approved catch-up immunization schedule for people age 4 months through 18 years who start vaccination late or who are more than one month behind. Essential explanatory footnotes are also included.

	MMWR article

	Adult Immunization Schedule

Recommended Immunization Schedule for Adults Aged 19 Years and Older, U.S., 2023   This schedule for adult vaccination provides recommendations by age group as well as by medical condition, essential footnotes, and a summary of contraindications and precautions for adult vaccine use.

	MMWR article

	Parent-Friendly Schedules

What Vaccines Does Your Child Need?

Infants and Children: Birth to 6 Years      Preteens and Teens: 7 to 18 Years	Resources to Encourage Routine Childhood Vaccinations

Centers for Disease Control and Prevention 1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348 Questions or Problems  |  Unsubscribe